Search tool

Displaying 131 - 140 of 999

EMCDDA building

Over 40 countries attend 2015 Reitox week in Lisbon

Representatives of candidate, potential candidate and neighbouring countries of the EU are joining members of the EMCDDA’s Reitox network in Lisbon today for the kick-off of the agency’s fourth Reitox week.

Drugnet 92 cover

Drugnet Europe 92

In this issue: Lisbon Addictions 2015 — conference round-up | Sponsored sessions at Lisbon Addictions 2015 | EMCDDA 20 years of monitoring conference | EMCDDA signs Memorandum of Understanding with Georgia |...

Director with Georgian Minister of Justice

EU drugs agency boosts cooperation with Georgian Ministry of Justice

EMCDDA Director Wolfgang Götz and the Georgian Minister of Justice Tea Tsulukiani meet in Tbilisi to sign a Memorandum of Understanding (MoU).

MT-45 molecule

4,4'-DMAR and MT-45 to be placed under control across the EU

Europe has responded to rising concerns over the use of two new drugs by subjecting them to ‘control measures and criminal penalties’ throughout the Union. The implementing decision of the Council of...

Small cover

Report on the risk assessment of 4,4′-DMAR in the framework of the Council Decision on new psychoactive substances

This publication presents the data and findings of the risk assessment on 4,4’-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine), carried out by the extended Scientific Committee of the EMCDDA on 16 September 2014. The main part of...

Small cover

Report on the risk assessment of MT-45 in the framework of the Council Decision on new psychoactive substances

This publication presents the data and findings of the risk assessment on MT-45 (1-cyclohexyl-4-(1, 2-diphenylethyl)piperazine), carried out by the extended Scientific Committee of the EMCDDA on 16 September 2014. The main part...

Wastewaters

EMCDDA co-hosts ‘Testing the waters 2015’

The EU drugs agency (EMCDDA) is co-hosting next week in Ascona, Switzerland, the second international conference on wastewater analysis: ‘Testing the waters 2015’. The event, to be held from 11–15 October, is...

Publication's cover

20 years: Monitoring, Communicating evidence, Informing policy

In 2015, the EMCDDA commemorates 20 years of monitoring the drugs problem in Europe. This brochure provides a summary of the agency’s key achievements over the period, along with a timeline showing...

Publication's cover

EMCDDA–Europol Joint Report on a new psychoactive substance: 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (α-PVP)

In May 2015, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone, commonly known as α-pyrrolidinovalerophenone (α-PVP), through a joint assessment. The two organisations concluded that sufficient...

Poster thumbnail

Ageing and addiction: challenges for treatment systems (poster)

Historically, problem opioid users, mainly injectors, have always represented the largest client group receiving specialised drug treatment in the European Union. The needs of large cohorts that started heroin injecting during the...